Mather Group LLC. Raises Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Mather Group LLC. grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 7.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,926 shares of the medical device company’s stock after purchasing an additional 133 shares during the quarter. Mather Group LLC.’s holdings in Cooper Companies were worth $177,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in COO. Alliance Wealth Advisors LLC UT boosted its position in Cooper Companies by 3.8% in the 4th quarter. Alliance Wealth Advisors LLC UT now owns 11,262 shares of the medical device company’s stock valued at $1,035,000 after buying an additional 416 shares during the period. Boston Trust Walden Corp raised its stake in shares of Cooper Companies by 10.0% in the fourth quarter. Boston Trust Walden Corp now owns 1,379,290 shares of the medical device company’s stock valued at $126,798,000 after acquiring an additional 125,475 shares in the last quarter. Jennison Associates LLC boosted its holdings in Cooper Companies by 9.3% in the fourth quarter. Jennison Associates LLC now owns 885,598 shares of the medical device company’s stock valued at $81,413,000 after purchasing an additional 75,015 shares during the period. Greenleaf Trust grew its stake in Cooper Companies by 5.0% during the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock worth $268,000 after purchasing an additional 139 shares in the last quarter. Finally, Caprock Group LLC purchased a new stake in Cooper Companies during the 4th quarter worth about $282,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Down 1.4 %

Shares of NASDAQ COO opened at $95.29 on Friday. The business has a 50-day moving average price of $95.21 and a 200 day moving average price of $99.72. The stock has a market cap of $19.02 billion, a PE ratio of 48.87, a price-to-earnings-growth ratio of 2.45 and a beta of 1.00. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period last year, the firm posted $0.87 earnings per share. The company’s revenue for the quarter was up 9.8% compared to the same quarter last year. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on COO shares. Wells Fargo & Company lifted their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Finally, Citigroup cut their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.